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Purpose: Enhanced S Cone Syndrome is a rare autosomal recessive disorder characterized clinically by an absence of
rod function, a replacement of most L and M cone function by S cone activity (Goldmann-Favre Syndrome) and by variable
degrees of retinal degeneration in different families. The causative gene, nuclear receptor subfamily 2, group E, member
3 (NR2E3), controls the developmental sequence for rods and cones. The purpose of this study was to compare the nature
and implications of mutations in two subjects with Enhanced S Cone Syndrome who have significantly different degrees
of degenerative damage.
Methods: A direct sequencing approach was used to identify the mutations. Genomic DNA was amplified from all the
exons of NR2E3 and used as a template for sequencing. Of the two families studied, Case 1 is of Persian ethnicity while
Case 2 is Brazilian. A total of six individuals within the two families were studied.
Results: Case 1 (original propositus of the syndrome) has the characteristic developmental rod/cone abnormality with
large amplitude electroretinogram responses and no retinal degeneration. She was homozygous for a novel mutation, c.
[del196–201del6] (p.G66-C67del), which lies entirely within the P-box for this gene. By comparison, Case 2 had
Goldmann-Favre  Syndrome  with  retinal  degeneration  and  low  electroretinogram  signals.  She  was  a  compound
heterozygote for c.[119–2A>C]+[del194–202del9] (p.N65-C67del), mutations that have been reported previously. Her
second mutation overlaps that of Case 1 within the P-box.
Conclusions: The novel in-frame homozygous deletion of Case 1, within the P-box motif of the DNA binding domain,
caused  a  developmental  abnormality  without  retinal  degeneration.  Case  2,  with  more  traditional  Goldmann-Favre
Syndrome with retinal degeneration, was a compound heterozygote where one allele had a similar P-box deletion but the
other was a splicing defect. Case 1 is the first reported homozygous deletion within the P-box. This is the first report of
NR2E3 mutations in a Persian and a Brazilian family.
Enhanced S Cone Syndrome (ESCS) is a rare autosomal
recessive  retinal  disorder  that  overlaps  clinically  with  the
more severe Goldmann-Favre Syndrome. It is characterized
clinically by an absence of rod function and a replacement of
most L and M cone activity by S cone responsiveness [1-3].
The  diagnosis  is  determined  by  characteristic
electroretinogram (ERG) findings of no rod activity and large
S cone–mediated responses under both photopic and scotopic
conditions. There may also be retinal degenerative changes in
a circular pattern about the arcades, and cystic edema in the
fovea,  which  carry  the  designation  of  Goldmann-Favre
Syndrome and are associated with a considerable loss of visual
acuity and visual field [2,3]. There is debate as to whether
ESCS is largely static or progressive, and there is variability
among different families [4-8].
The gene for ESCS on chromosome 15q23 was originally
identified by Haider et al. [9], and was termed nuclear receptor
subfamily 2, group E, member 3 (NR2E3). It encodes a nuclear
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receptor  ligand-dependent  transcription  factor.  The
expression of this gene was localized to the outer nuclear layer
of the human retina [10,11], as well as other animal models
[12-14]. This influences the development of photoreceptors
and their differentiation into rod and cone types [15-18]. In
ESCS, rods fail to develop and are replaced largely by cells
that behave physiologically as S cones. L and M cones are
reduced in number. Different abnormalities in the NR2E3
gene  have  been  reported,  and  individuals  with  ESCS
manifestations may be either homozygous or heterozygous.
Most of these reports involve patients with significant levels
of  retinal  degeneration  and  visual  dysfunction.  NR2E3
mutations including the common mutation c.119–2A>C have
been reported in clumped pigmentary retinal dystrophy [19].
Autosomal dominant/recessive retinitis pigmentosa patients
also have been shown to carry the common p.G56R (RP37)
mutation [20-22].
We had access to the original propositus [1], a unique case
that might elucidate the distinction between photoreceptor
developmental  abnormality  and  retinal  degeneration.  This
case was first described because of her unusual ERG, showing
large amplitude signals with a characteristic S cone pattern
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519but  with  essentially  no  degenerative  changes.  We  have
sequenced the gene from her family as well as that from
another family with more typical Goldmann-Favre Syndrome,
to see if the results might give clues to the phenotypic variation
in ESCS (development versus degenerative change). It raises
the  intriguing  question  of  how  certain  in  frame  deletion
mutations  within  the  ligand  binding  domain  results  in  a
developmental only defect.
METHODS
The study was approved by the Institutional Review Board of
the University of California Los Angeles (UCLA-HSPC 94–
07–243–03).  Informed  consent  was  obtained  from
participants and the study was performed according to the
tenets of the Helsinki Declaration. The patients were given
full  ophthalmological  exams,  and  ERGs  were  performed
according  to  the  International  Society  for  Clinical
Electrophysiology of Vision (ISCEV) standards.
Samples: A total of six individuals from two families
(Family 1: #2743, 3385, 3386, 3387 and Family 2: #2883,
2884) in good health were studied. DNA was extracted from
whole blood lymphocytes, using the Gentra blood extraction
kit  (Qiagen,  Chatsworth,  CA).  PCR  amplification  of  the
genomic DNA was performed using intronic primers to the
human  NR2E3  gene  (Table  1).  The  PCR  products  were
separated on agarose gel; bands were cut and then purified
using a Qiagen DNA gel purification kit (Qiagen).
TABLE 1. PRIMER SEQUENCE
                          Primer Primer sequence (5′-3′)
NR2E3–1AF AGCATGGGGTAGCAGGACTGAC
NR2E3–1AR TTGGTCTGGTCTCCATGGGTTAC
NR2E3–1BF GGCAGCTCCTGAGTTCAGACAGA
NR2E3–1BR CTGAGTTGTTCTGGCTCCTTCCA
NR2E3–2F GTTCGTTCAAATGCGGGTGAG
NR2E3–2R GGTCAGTGTCCCTCCCATGC
NR2E3–3F AGGGGTTCTGGAGGGGTGAG
NR2E3–3R GGACTCAGTGTTGGACTCCATGC
NR2E3–4AF CAGGCGGGGATGAACCAG
NR2E3–4AR TTATAAGGCTGGCCATGAAGTGG
NR2E3–4BF GCATGGAGTCCAACACTGAGTCC
NR2E3–4BR TGTGATCTTAGCGCCTGCTTCTC
NR2E3–5AF AGGATGGTGAGTGGGAGAGCAG
NR2E3–5AR ATGAAGAGTAGGCGAGCCGAGGT
NR2E3–5BF CCTGAGTTCCCCTCCTCTCCATA
NR2E3–5BR ATCACCATCCAAGCTGTGTGCAT
NR2E3–6AF CTGGCTGATGTCAGGAGAGCATT
NR2E3–6AR CCGGAACCGAGAGATAGTTTCCT
NR2E3–6BF GGCGTGGAGTGAACTCTTTCTCC
NR2E3–6BR AGTCCAGCCTCACCACTCTCCTC
NR2E3–7AF CAGAGCCCACCCCACAGG
NR2E3–7AR TGAACTGAGACCCTTGTGCTGTC
NR2E3–7BF CCCGTGAGGTGACCTGAGCAT
NR2E3–7BR CAAAGTCCCTCCCAATTCTGCTT
NR2E3–7CF CCCTAGCCAGGTACTGAGGGTTG
NR2E3–7CR AGCCCTGTGTATGACCCTCTGCT
NR2E3–7DF AGCCCGTTCAGGACTTTGAATG
NR2E3–7DR TCCATGTGCTTGGCATCTCTACA
NR2E3–8AF ATGTGGCTTTTCCTCGAAATTCCT
NR2E3–8AR CCATCAATATACAGTTTGGGGCTAT
NR2E3–8BF GCAATTCCTCGTAGGTGTGTGTACC
NR2E3–8BR TGCCCAGATCAAAATCAACATTTCT
NR2E3–8CF TATGCAGAGTTCAGGAACAGGCAAG
NR2E3–8CR GGGTGGTTGAATTCTATGGGAGATT
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520DNA  sequencing:  The  purified  DNA  was  sequenced
using a Thermo Sequenase Radiolabeled Terminator Cycle
Sequencing Kit (USB, Cleveland, OH) and electrophoresed
on a 6.5% acrylamide gel containing 7 M urea and 1× TBE
containing 90mM Tris, 45 mM Tris-borate and 1 mM EDTA
pH 9.5 on a DNA sequencing apparatus (Biorad, Hercules,
CA) at 80 W in 1× TBE.
The NR2E3 reference sequence NM_014249.2 was used
as the reference RNA sequence and the AJ276674 genomic
assembly was used for the DNA sequence.
RESULTS
Case 1 (propositus):
Clinical findings—The propositus of ESCS is a Persian
female (#2743) first seen at age 10 years because of night
blindness. No other immediate family members were reported
to be affected. She was otherwise asymptomatic, and had a
visual acuity 20/25 on the right, 20/20 on the left. Visual fields
and color vision were normal, and a retinal exam was normal
except for a few sparse yellowish spots in the arcade regions.
Vascular caliber was full, and she had a normal foveal reflex.
Her ERG showed no detectable rod signal, but large amplitude
slow scotopic responses that hardly changed under photopic
conditions were observed (Figure 1) [1]. These findings were
stable  on  follow-up  nine  years  later  [4].  Multifocal  ERG
testing showed L and M cone function mixed in with the S
cone responses in the central 9° of the macula. The individual
represents an unusual extreme of ESCS in which there are
essentially  no  stigmata  of  the  retinal  degeneration  of  the
Goldmann-Favre Syndrome.
Genetic findings—After amplification of all exons of
NR2E3, we sequenced them for patient #2743. Using these
data, we identified a homozygous in-frame deletion mutation
c.del196–201del6 (p.G66-C67del; Figure 2). We amplified
exon 2 for all three family members (parents #3385, #3387
and brother #3386; Figure 2). None of the family members
had the ESCS phenotype. DNA sequencing results revealed
that both the parents (#3385 and #3387) were heterozygous
for  the  mutation  (data  not  shown).  The  patient’s  brother
(#3386)  was  negative  for  the  mutation  (data  not  shown),
suggesting  that  he  inherited  the  normal  allele  from  both
parents. As shown in Figure 3, this novel mutation is located
within the conserved P-box of the DNA binding domain.
Case 2:
Clinical findings—This 29-year-old Brazilian woman
had been night blind all of her life, and had poor vision in the
right eye for many years [23]. Her parents were not affected.
Visual acuity was 20/400 on the right and 20/40 on the left.
Fundus examination showed mildly attenuated arteries and a
zone in the midperiphery of diffuse depigmentation and faint
yellow spots. The central macula was grossly cystic on the
right  but  minimally  so  on  the  left.  She  had  a  chronic
fluctuating uveitis and vitritis in the right eye, which affected
her visual acuity, but never had uveitic attacks on the left.
Goldmann visual fields were not testable on the right because
of poor vision, and showed generalized constriction on the
left. Her ERG responses were similar in the two eyes, and
showed no detectable rod responses. However, she had slow
and  low  amplitude  b-waves  to  a  strong  flash,  of  similar
waveform,  under  both  scotopic  and  photopic  conditions
(Figure  1).  The  ERG  was  unchanged  on  a  follow-up
examination  two  years  later.  Her  clinical  diagnosis  was
Goldmann-Favre Syndrome.
Genetic  findings—Sequencing  of  all  exons  was
performed after amplification of genomic DNA for the patient
#2883 (Figure 4). The results revealed that the patient has a
compound heterozygous mutation, which was c.[119–2A>C]
+[del194–202del9]  (Figure  4).  The  mother  (#2884)  was
heterozygous for the mutation c.del 194–202del9 (data not
shown)  and  a  normal  allele.  As  shown  in  Figure  3,  this
Figure 1. Electroretinograms comparing normal tracings to Case 1 and Case 2. Case 1 shows electroretinogram (ERG) amplitudes similar to
the normal dark-adapted combined rod-cone response under both scotopic and photopic conditions (Scale bars show amplitude 500 microvolts,
duration 75 ms). The responses from Case 2 have similar waveform, and scotopic-photopic homology, but lower amplitude.
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binding domain. We were unable to obtain DNA from the
father. Patient #2883 could have inherited the c.[119–2A>C]
mutation from the father, or it could have been a de novo event.
This combination of mutation has previously been reported in
another case [9,19].
DISCUSSION
From a clinical standpoint, our two cases are quite different.
Case  1,  which  has  been  described  previously  in
electrophysiological studies [1-3], lies at one extreme of the
ESCS complex, being essentially free of Goldmann-Favre
stigmata and without evidence of degeneration. The patient’s
ERG signals are of comparable amplitude to a normal “mixed
rod-cone” ERG, which suggests the presence of functional S
cones in numbers comparable to the photoreceptor density of
the normal retina. This striking developmental abnormality
results from a small deletion of “ggctgc” at position c.196–
201 (see Figure 3), which lies within the P-box region that has
been described for this gene [12-14,24]. The P-box of nuclear
Figure  2.  DNA  sequencing  of  the
NR2E3  gene  in  family  1  with  the
propositus  #2743  showing  the
homozygous  deletion.  Pedigree:  +  -
indicate  individual  that  have  been
examined. Black solid fill ● – affected
phenotype. White solid fill □ – normal
phenotype.  Pattern  filled  square  and
circle– individual assumed carrier. # -
Sample Number.
Figure 3. Sequence of intron 1 and exon 2 of NR2E3 showing the mutations of Case 1 and 2. Repeat sequences are given in bold. The novel
mutations of Case 1 are underlined. The mutations of Case 2 are shaded. A square box defines the P-box.
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receptors with specific response elements in DNA upstream
of target genes, and thus the control of gene expression. It is
perhaps relevant that there is a similar “gcctgc” sequence at
position c.187, and a “ggcttc” at position c.205. The sequence
can also be viewed as a direct repeat TGCA(A/G)CGGC at
position 190 and 199 within the P Box.
The  spectrum  of  clinical  phenotypes  with  NR2E3
abnormalities  is  wide,  and  includes  clumped  pigmentary
degeneration and autosomal dominant retinitis pigmentosa as
well as ESCS and Goldmann-Favre Syndrome [20,22,25,26].
Three recent reports have discussed possible mechanisms by
which the degenerative component of the ESCS complex may
vary  greatly  [7,27,28].  Cases  with  surprisingly  little
degenerative change have been reported with variations of the
c.119–2A>C  mutation  [27,28].  Our  report  adds  to  this
growing body of evidence that mutations in this gene lead to
a  developmental  defect  and/or  degenerative  changes.
Whereas the P box deletion [del194–202del9] of Case 2 has
previously been reported with varying phenotypes [7,9,19,
21,27], we believe Case 1 is the first homozygous deletion
within the P-box to be reported, and to define this locus as
possibly developmental (although we recognize that a single
case cannot confirm this conclusion).
Case  2  would  be  diagnosed  as  Goldmann-Favre
Syndrome,  although  not  a  terribly  severe  example.  The
individual  is  somewhat  similar  to  the  “mild  phenotype”
reported by Hayashi et al. [29] in a Japanese patient with two
missense mutations. Her chronic uveitis in one eye has not
been reported as a component of this syndrome, and could be
a new or an unrelated finding. It is interesting that her foveal
cystic changes were markedly accentuated as a result of the
uveitis, and visual acuity was only mildly reduced in the left
eye  where  cystic  changes  were  minimal.  This  individual
exhibited  the  splice  junction  c.[119–2A>C],  which  is
responsible for her developmental as well as degenerative
changes.  The  c.119–2A>C  change  is  the  most  common
mutation  found  in  ESCS,  autosomal  recessive  retinitis
pigmentosa  (arRP),  and  clumped  pigmentary  retinal
dystrophy patients [7,9,19,30].
The second mutation in Case 2 is also located within the
P-box. This is the first ESCS mutation reported in a Brazilian
patient. Due to nomenclature recommendations, this mutation
is  designated  as  c.[119–2A>C]+[del194–202del9  (p.N65-
C67del)]. However this does not rule out the possibility that
this  mutation  is  actually  [119–2A>C]+[del  190–198del9]
(p.C64-G66del). Results using Sanger DNA sequencing in
either direction would essentially give identical results for
either  of  the  two  above  mentioned  mutations  due  to  the
presence of a short sequence repeat. However the amino acid
translations are different for the above-mentioned mutations.
Therefore, one has to be cautious in assuming the nature of
p.N65-C67del versus p.C64-G66del mutation in all reported
cases. Although functional assays have been developed by
Kanda  et  al.  [31],  these  may  not  be  able  to  differentiate
between these changes at the functional level.
We  hypothesize  that  the  NR2E3  protein  could  have
functions  beyond  the  developmental  process  that  are
independently controlled and lead to degeneration. We also
hypothesize that the presence of direct repeats near the 5′ end
of exon 2 and another repeat within the P-box may lead to
looping structures in the DNA within these two respective
regions.  A  consequence  of  this  could  lead  to  errors  in
replication [20]. These are de novo events and are not related
to mutations that are inherited.
Figure  4.  DNA  sequencing  of  the
NR2E3  gene  in  family  2.  Individual
#2883  illustrates  the  compound
heterozygous  mutation.  Pedigree:  +  -
indicate  individual  that  have  been
examined. Black solid fill ● – affected
phenotype. White solid fill □ – normal
phenotype.  Pattern  filled  square  and
circle– individual assumed carrier. # -
Sample Number.
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overlapping this region at amino acid position p.N65-C67 to
seven reports in seven different families [9,19,21,27]. The
synonymous variation at position c.195 C>T, N65N reported
by Bernal et al. [30] overlaps with this region as well. It is
possible  that  these  mutations  are  random  events  and  not
specific for a family/ethnicity; however, this will need to be
verified in the future by genotyping these samples with closely
linked  markers.  We  hope  that  further  studies  on  the
phenotypic  variability  of  this  syndrome  will  enhance  the
understanding of how both retinal development and retinal
degeneration are controlled.
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